Hyperfine Inc (HYPR) Stock Price, Quote & News

Company Profile

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departm...

Industry: Medical Devices

Sector: Healthcare

Phone: 866 796 6767

Website: www.hyperfinemri.com

Address:

351 New Whitfield Street, Guilford, United States

TheWideOpenRoad May. 13 at 11:20 AM

$HYPR

0 · Reply

TheWideOpenRoad May. 13 at 11:04 AM

$HYPR

0 · Reply

OfficialStocktwitsUser May. 13 at 3:52 AM

$HYPR RSI: 73.12, MACD: 0.1437 Vol: 0.22, MA20: 1.50, MA50: 1.29 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

MarketBeat May. 13 at 12:25 AM

https://marketbeat.com/a/8651173/ $HYPR Hyperfine Q1 Earnings Call Highlights

0 · Reply

TheWideOpenRoad May. 12 at 11:34 PM

$HYPR why is this sentiment thingy always saying “bearish” ???

0 · Reply

EarningsInsider May. 12 at 9:32 PM

https://www.marketbeat.com/earnings/reports/2026-5-12-hyperfine-inc-stock/ $HYPR Hyperfine Earnings Transcript

0 · Reply

Cold_in_the_North May. 12 at 9:08 PM

$HYPR nothing to dislike here. This are still moving forward in a very healthy manner for a company that’s at the stage it’s at.

0 · Reply

TheWideOpenRoad May. 12 at 9:08 PM

$HYPR $BFLY Hyperfine had 83% growth y-o-y! Congrats!!!

0 · Reply

permedbull May. 12 at 9:01 PM

$HYPR the bigger the base the higher in space

0 · Reply

StocktwitsEarnings May. 12 at 8:13 PM

$HYPR Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.09 up 25.00% YoY • Reported revenue of $3.9M up 82.64% YoY

0 · Reply

Hyperfine reports Q1 EPS (9c), consensus (9c)

2026-05-12T22:00:18.000Z - 13 hours ago

Hyperfine still sees FY26 revenue $20M-$22M, consensus $20.04M

2026-05-12T20:51:05.000Z - 15 hours ago

Hyperfine files to sell 1.08M shares of Class A common stock for holders

May 12, 2026, 4:30 PM EDT - 15 hours ago

Hyperfine Earnings Call Transcript: Q1 2026

May 12, 2026, 4:05 PM EDT - 15 hours ago

Hyperfine, Inc. Reports First Quarter 2026 Financial Results

May 6, 2026, 4:05 PM EDT - 6 days ago

Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference

2026-04-29T14:46:17.000Z - 13 days ago

Hyperfine announces AIIMS New Delhi initiated clinical use of Swoop

Apr 29, 2026, 8:15 AM EDT - 13 days ago

Hyperfine Swoop® System Introduced as India's First Portable MRI for Bedside Brain Imaging at the Country's Leading Medical Institution

2026-04-29T11:33:03.000Z - 14 days ago

Hyperfine initiated with a Buy at BTIG

Apr 28, 2026, 4:05 PM EDT - 14 days ago

Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026

2026-04-09T14:24:32.000Z - 4 weeks ago

Hyperfine receives CE Marking, UK Conformity Assessment approval

Apr 9, 2026, 8:15 AM EDT - 4 weeks ago

Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software

2026-03-23T12:10:42.000Z - 7 weeks ago

Horizon Technology provides $40M loan facility to Hyperfine

HRZN

Mar 23, 2026, 8:00 AM EDT - 7 weeks ago

Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine

HRZN

2026-03-19T12:56:16.000Z - 7 weeks ago

Hyperfine price target raised to $1.60 from $1.30 at B. Riley

2026-03-19T12:45:51.000Z - 7 weeks ago

Hyperfine price target raised to $2.50 from $2 at Lake Street

Mar 18, 2026, 4:30 PM EDT - 7 weeks ago

Hyperfine Earnings Call Transcript: Q4 2025

2026-03-18T20:12:26.000Z - 7 weeks ago

Hyperfine reports Q4 EPS (6c) vs (14c) last year

2026-03-18T20:12:21.000Z - 7 weeks ago

Hyperfine sees FY26 revenue $20M-$22M, one estimate $18M

Mar 18, 2026, 4:05 PM EDT - 7 weeks ago

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 5, 2026, 4:05 PM EST - 2 months ago

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Jan 27, 2026, 8:15 AM EST - 3 months ago

Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System's Enhanced Stroke Detection Capabilities

2026-01-20T13:20:42.000Z - 4 months ago

Hyperfine announces results from NEURO PMR study

Jan 20, 2026, 8:15 AM EST - 4 months ago

Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics

2026-01-15T13:21:26.000Z - 4 months ago

Hyperfine enrolls first patient in Contrast PMR study

Jan 15, 2026, 8:15 AM EST - 4 months ago

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

2026-01-12T13:41:42.000Z - 4 months ago

Hyperfine reports preliminary Q4 revenue $5.3M, consensus $5M

Jan 12, 2026, 8:15 AM EST - 4 months ago

Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results

Jan 6, 2026, 8:15 AM EST - 4 months ago

Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care

2025-12-17T13:36:39.000Z - 5 months ago

Hyperfine announces regulatory approval of Swoop System in India

Dec 17, 2025, 8:15 AM EST - 5 months ago

Hyperfine Announces Regulatory Approval of the Swoop® System in India

2025-12-15T13:26:41.000Z - 5 months ago

Hyperfine gets FDA clearance for diffusion-weighted imaging software sequence

Dec 15, 2025, 8:15 AM EST - 5 months ago

Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System

Dec 4, 2025, 8:10 AM EST - 5 months ago

Hyperfine Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 20, 2025, 4:05 PM EST - 6 months ago

Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference

2025-11-19T13:45:26.000Z - 6 months ago

Hyperfine receives $3.7M Gates Foundation grant

Nov 19, 2025, 8:15 AM EST - 6 months ago

Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health

Nov 13, 2025, 4:30 PM EST - 6 months ago

Hyperfine Earnings Call Transcript: Q3 2025

2025-11-13T21:10:51.000Z - 6 months ago

Hyperfine reports Q3 EPS (14c) vs. (14c) last year

2025-11-13T21:10:34.000Z - 6 months ago

Hyperfine sees Q4 revenue $5M-$6M, consensus $6.0M

Nov 13, 2025, 4:05 PM EST - 6 months ago

Hyperfine, Inc. Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 4:05 PM EDT - 6 months ago

Hyperfine, Inc. to Announce Third Quarter 2025 Financial Results on November 13, 2025

2025-10-21T13:10:40.000Z - 7 months ago

Hyperfine enrolls first patient in PRISM PMR study

Oct 21, 2025, 8:15 AM EDT - 7 months ago

Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting

Oct 16, 2025, 8:00 AM EDT - 7 months ago

Hyperfine Announces Pricing of $17.5 Million Public Offering

Oct 15, 2025, 4:06 PM EDT - 7 months ago

Hyperfine Announces Proposed Public Offering

Oct 15, 2025, 4:05 PM EDT - 7 months ago

Hyperfine Reports Preliminary, Unaudited Results for Third Quarter 2025, Signaling Strong Business Momentum Following the Launch of the Next Generation Swoop® System

Oct 13, 2025, 8:15 AM EDT - 7 months ago

Hyperfine Swoop® System Referenced in France's Largest Public Hospital Procurement Body to Facilitate Nationwide Purchases of Portable MRI Technology

Oct 6, 2025, 8:15 AM EDT - 7 months ago

Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI

Sep 8, 2025, 12:00 PM EDT - 8 months ago

Hyperfine Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:15 AM EDT - 9 months ago

Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software

Aug 25, 2025, 8:15 AM EDT - 9 months ago

Hyperfine, Inc. to Participate in Upcoming Investor Conferences

Aug 13, 2025, 4:30 PM EDT - 9 months ago

Hyperfine Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:05 PM EDT - 9 months ago

Hyperfine, Inc. Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 8:15 AM EDT - 10 months ago

Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System

Jul 31, 2025, 8:15 AM EDT - 10 months ago

Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments

Jul 30, 2025, 4:05 PM EDT - 10 months ago

Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025

Jul 28, 2025, 8:15 AM EDT - 10 months ago

Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzheimer's Association International Conference

Jul 24, 2025, 8:15 AM EDT - 10 months ago

Hyperfine Swoop® AI-Powered Portable MRI System Showcased in Clinical Studies Designed to Broaden Access to Dementia Care

Jul 23, 2025, 8:15 AM EDT - 10 months ago

Hyperfine Begins Commercial Launch of Optive AI™ Software, Bringing Substantially Improved Image Quality to the Installed Base of Swoop® Systems

Jul 17, 2025, 8:15 AM EDT - 10 months ago

Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop® System Powered by Optive AI™ Software

Jun 11, 2025, 9:00 AM EDT - 11 months ago

Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI

Jun 5, 2025, 4:20 PM EDT - 1 year ago

Hyperfine Transcript: Jefferies Global Healthcare Conference 2025

Jun 2, 2025, 8:15 AM EDT - 1 year ago

Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality

May 28, 2025, 9:00 AM EDT - 1 year ago

Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System

May 15, 2025, 4:05 PM EDT - 1 year ago

Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference

May 13, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Earnings Call Transcript: Q1 2025

May 13, 2025, 4:05 PM EDT - 1 year ago

Hyperfine, Inc. Reports First Quarter 2025 Financial Results

Apr 29, 2025, 4:28 PM EDT - 1 year ago

Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025

Apr 15, 2025, 4:00 PM EDT - 1 year ago

Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices

Mar 17, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Earnings Call Transcript: Q4 2024

Mar 17, 2025, 4:05 PM EDT - 1 year ago

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 4, 2025, 4:05 PM EST - 1 year ago

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Feb 11, 2025, 8:02 AM EST - 1 year ago

Hyperfine Announces $6.0 Million Registered Direct Offering

Feb 6, 2025, 4:05 PM EST - 1 year ago

Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference

Dec 17, 2024, 9:00 AM EST - 1 year ago

Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets

Dec 5, 2024, 9:00 AM EST - 1 year ago

Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care

Dec 3, 2024, 9:00 AM EST - 1 year ago

Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals

Nov 21, 2024, 9:00 AM EST - 1 year ago

Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body

TheWideOpenRoad May. 13 at 11:20 AM

$HYPR

0 · Reply

TheWideOpenRoad May. 13 at 11:04 AM

$HYPR

0 · Reply

OfficialStocktwitsUser May. 13 at 3:52 AM

0 · Reply

MarketBeat May. 13 at 12:25 AM

https://marketbeat.com/a/8651173/ $HYPR Hyperfine Q1 Earnings Call Highlights

0 · Reply

TheWideOpenRoad May. 12 at 11:34 PM

$HYPR why is this sentiment thingy always saying “bearish” ???

0 · Reply

EarningsInsider May. 12 at 9:32 PM

https://www.marketbeat.com/earnings/reports/2026-5-12-hyperfine-inc-stock/ $HYPR Hyperfine Earnings Transcript

0 · Reply

Cold_in_the_North May. 12 at 9:08 PM

$HYPR nothing to dislike here. This are still moving forward in a very healthy manner for a company that’s at the stage it’s at.

0 · Reply

TheWideOpenRoad May. 12 at 9:08 PM

$HYPR $BFLY Hyperfine had 83% growth y-o-y! Congrats!!!

0 · Reply

permedbull May. 12 at 9:01 PM

$HYPR the bigger the base the higher in space

0 · Reply

StocktwitsEarnings May. 12 at 8:13 PM

$HYPR Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.09 up 25.00% YoY • Reported revenue of $3.9M up 82.64% YoY

0 · Reply

permedbull May. 12 at 2:48 AM

$HYPR gl to the few watching this tomorrow. i was impressed with their last cc

0 · Reply

Number_4 May. 11 at 5:15 PM

$HYPR FYI- Google's venture arm invested in a HYPR private placement before the SPAC merger with the Catalio public shell. So did Cathie Wood, who sold at a huge loss. Nothing burger. Mgmt still sucks and they cannot sell machines.

1 · Reply

MorganHoratio May. 8 at 1:36 PM

Google just released its updated 13F filing which shows all the stocks it owned as of the end of Q1: $HYPR - 898,720 $LYEL - 293,256 $MAZE - 1,388,583 $GLUE - 684,275 $OSCR - 481,988 Google's Q1 13F reveals a sharp focus: Cybersecurity Bedrock + AI Bio-Engineering! The stake in $HYPR is a massive signal—in a 2026 defined by AI deepfakes, Google is leaning on $HYPR's passwordless tech to fortify its Gemini ecosystem. Meanwhile, the heavy lifting in $MAZE and $GLUE proves Alphabet is no longer just indexing information, but indexing "cures" through AI-led protein modeling. With $OSCR hitting its profitability inflection point, do you think Google is just building an AI-health moat, or are we looking at the early days of its next multi-billion dollar "Other Bet" breakout? Let's discuss your top small-cap pick!

3 · Reply

TheWideOpenRoad May. 8 at 11:27 AM

$HYPR The panel discussion was very positive. They made it sound like a no-brainer for a hospital to buy one. In fact, one Doctor said he was probably buying two more. One of these days, Swoop sales are going to explode! But waiting for it is like watching paint dry ...

2 · Reply

TheWideOpenRoad May. 8 at 11:24 AM

$HYPR

0 · Reply

permedbull May. 8 at 4:48 AM

$HYPR 🚩

0 · Reply

Cold_in_the_North May. 6 at 10:30 PM

$HYPR https://investors.hyperfine.io/news-releases/news-release-details/hyperfine-inc-participate-upcoming-2026-jefferies-global

0 · Reply

TheWideOpenRoad May. 6 at 8:23 PM

$HYPR Tomorrow at 4:00, there is a panel discussion: “How portable MRI is transforming stroke care and unlocking scalable stroke programs” I got an email invite

0 · Reply

white_knuckling May. 5 at 1:41 PM

$HYPR y the drop this morning?

0 · Reply

TheWideOpenRoad May. 5 at 12:20 PM

$HYPR All we need is one big order from a large hospital chain and we are headed to $3.00 !!!

0 · Reply

permedbull May. 4 at 7:00 PM

$HYPR some of this new volume must be going to toots

0 · Reply

permedbull May. 4 at 6:05 PM

$HYPR its that time

0 · Reply

Market Cap	171.43M
Revenue (ttm)	13.56M
Net Income (ttm)	-35.57M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-262.32%
Debt to Equity Ratio	0.00

Volume	820,000
Avg Vol	626,770
Day's Range	N/A - N/A
Shares Out	97.96M
Stochastic %K	59%
Beta	1.42
Analysts	Strong Sell
Price Target	$2.03